a b s t r a c t b-Tricalcium phosphate (b-TCP) is a suitable biomaterial in oral and maxillofacial surgery since it can induce a rapid proliferation of woven bone. Granules, prepared by the polyurethane foam method, were implanted in critical size defects performed in the femoral condyles of New Zealand rabbits. Animals were studied after 8 and 28 days. Ketoprofen (a non-steroidal anti-inflammatory drug (NSAID)) was given for 8 and 28 days to evaluate its effects on the healing of the graft. Before euthanasia, the rabbits received an intravenous injection of fluorescent microbeads. Bones were analyzed by microcomputed tomography. b-TCP granules induced metaplastic bone trabeculae as early as 8 days post-surgery. At 28 days, the amount of bone was increased and the biomaterial volume decreased due to simultaneous macrophagic resorption. The amount of macrophages labeled with microbeads was less in the grafted area than in the vicinal intact marrow spaces. Ketoprofen had no effect on the amount of bone formed and on the number of labeled macrophages. The influence of small doses of NSAID, given in a short duration period, did not present deleterious effects on bone graft healing.
Introduction
Synthetic calcium/phosphate biomaterials are nowadays currently used for the repair of bone defects. They offer considerable safety compared with bone allografts or xenogenic bone. An ideal biomaterial must be able to induce a localized osteogenesis which constitutes the first step of the ossification process by a modeling process; it should be followed by a phase of resorption of the material. Tricalcium phosphate (b-TCP) has been recognized as a suitable ceramic material with bioactive properties for several decades [1] [2] [3] . b-TCP is used in maxillofacial and orofacial surgery and in dental implantology but has received little attention in orthopedics because of its friability, which precludes its use in weight-bearing areas [4] [5] [6] [7] . Mixtures of b-TCP and hydroxyapatite (HA) have been proposed (and are often referred as BCP -biphasic calcium phosphate) [8] . However, BCP properties depend on an optimum balance between the HA phase (more stable) and the b-TCP phase (more soluble) and controversies exist concerning to how long HA persists in the body; reports from the orthopedic literature indicate that b-TCP provides better results [9] . However, b-TCP is known to be an excellent promotor of osteoblastic formation and is readily resorbed by macrophages and osteoclasts. Direct bone matrix anchorage has been shown with collagen fibers deposited in the micropores [10] . Resorption of b-TCP by giant cells has been recently reported in a rabbit model with cells having or not a ruffled border (a characteristic of osteoclasts) [10] .
Non-steroidal anti-inflammatory drugs (NSAIDs) have analgesic, antipyretic and anti-inflammatory properties. NSAIDs reduce fever, pain and they prevent inflammation. The ectopic new bone formation in the soft tissues around the hip joint can also be prevented by using NSAIDs [11] . A 14-day post-surgery treatment with ibuprofen has been shown to reduce the occurrence of chronic pain and disability with a low risk of adverse effects. NSAID treatments are simple and cheap to administer. However, a number of studies have reported adverse effects of NSAIDs which can delay the consolidation of fractures or the incorporation of the biomaterials because they interfere with the bone remodeling, in particular by their action on the production of prostaglandins [12] [13] [14] [15] [16] . In addition, these drugs have been found to impair tendon healing in preclinical studies [17] .
The aim of this work was to study the effect of a NSAID, ketoprofen, on the osteoconduction induced by a graft of b-TCP in a model of bone defect in the rabbit. Fluorescent microbeads of a biocompatible polymer (poly 2(hydroxyethyl methacrylate)-pHE-MA) were injected at the time of euthanasia to appreciate the macrophagic function in the grafted area.
Materials and methods
All chemical reagents were obtained from Sigma-Aldrich Chemical (Illkirsh, France). Commercial 2-hydroxyethyl methacrylate (HEMA) contains impurities, due to the fabrication process. The polymerization inhibitor 4-methoxyphenol (added by the manufacturer before shipping, at a concentration of 350 ppm) also needs to be removed. HEMA was purified and distilled under reduced pressure. Benzoyl peroxide (BPO) was recrystallized in methanol twice before use to remove impurities.
Preparation of pHEMA microbeads
Microbeads of pHEMA labeled with Nile red were prepared according to our previously reported protocol with minor modifications [18, 19] . Briefly, microbeads were prepared by an emulsion precipitation method by using the monomer HEMA (2-hydroxyethyl methacrylate). All reagents were obtained from Sigma-Aldrich (Saint-Quentin Fallavier, France). Benzoyl peroxide (2% w/v), a polymerization initiator, was dissolved in the monomer under magnetic stirring. The Nile red (2 mg), a fluorescent dye, was added. The diluent solution was made of a toluene/butanol mixture (40/60 v/v) in which a steric stabilizer, ethyl cellulose (3%, v/v), was dissolved. The diluent was heated at 40°C in a polymerization reactor; thereafter the monomer was added drop by drop in the reactor. Homogenization was done with an incorporated agitator. The mixture was maintained under nitrogen atmosphere for 15 min and temperature was increased to 75°C. After 2 h, the EGDMA (ethylene glycol dimethacrylate) (3% v/v), a cross-linking agent, was added. Thereafter, the reaction was left to complete for 6 h to obtain microbeads. After this period, microbeads were washed with Histo-Clear II Ò (a mixture of aliphatic hydrocarbon and distilled essential oils -food grade, reduced citrus odor, National Diagnostics, Atlanta, Georgia, USA) to eliminate monomer residues and to preserve fluorescence. They were centrifuged three times and washed in Histo-Clear II Ò , before dispersion and drying for 24 h. At the end, a powder containing millions of dried microbeads was obtained.
Animals and surgical procedure
Eighteen New Zealand rabbits (approximate weight 3.5 kg) were used in this study. They were acclimated for 8 days to the local vivarium conditions and received synthetic food and water ad libitum. Animals were randomly divided into two groups ( Fig. 1 Bilateral femoral implantations were performed under aseptic conditions and general anesthesia with medetomidine (Domitor Ò , Pfizer, Paris, France) and ketamin (Imalgène 1000 Ò , MERIAL SAS, Villeurbanne, France). After skin incisions and lateral arthrotomy access via the knee joint, a cylindrical defect (4 mm diameter and 6 mm long) was created at the distal femoral end and then filled with 1000-2000 lm b-TCP granules (Kasios, Launaguet-France) (Fig. 2 ).
The granules were placed after the cavity had been flushed with sterile saline to remove debris. Incision was closed by different layers with resorbable sutures. Implantation control was done to ensure that the b-TCP granules have been implanted in the right position.
The animals were sacrificed 8 and 28 days after implantation. 4 h before euthanasia, animals were injected in the ear marginal vein with a saline solution containing 3 Â 10 8 microbeads per ml. that pHEMA microbeads were rapidly internalized by endothelial cells and by in vivo experiments, indicating that microbeads were secondarily found in the cytoplasm of macrophages [19] . Then euthanasia was done by injecting an intracardiac overdose of sodium pentobarbital (Dolethal, Vetoquinol, France). The lower femoral extremities were immediately dissected from the animal and fixed in 10% formalin. The care and use of these laboratory animals were in compliance with French law on animal experimentation. Radiographs of the implanted bones were performed ex vivo using a Faxitron X-ray system (MX20, Edimex, Angers, France) with a 5 Â 5 cm CCD camera. The accelerating voltage was fixed at 35 kV with a 15 s exposure time.
b-TCP granules
b-TCP granules were prepared by the polyurethane foam technology and provided by Kasios (Launaguet, France) [20] . Granules were 1000-2000 lm in diameter and their morphology was verified by scanning electron microscopy. The sequence of operations for preparing sintered calcium phosphate materials is based on previous work presented in the literature [21] . Briefly, a slurry containing 25 g of b-TCP was prepared with distilled water and used to substantially impregnate a block of polyurethane foam under vacuum. This ensured that the ceramic coated the polyurethane walls to produce a replica of the reticulated foam material, the ceramic parts of the biomaterial being centered by the polymer. The blocks of polyurethane impregnated with the slurry were then dried in an oven and heated in a furnace oven at 800°C; this led to a complete burn of the organic polyurethane foam. The three-dimensional (3D) scaffolds of b-TCP were then sintered at a temperature >1200°C and granules were obtained by crushing the blocks in an alumina mortar.
Microtomography analysis (MicroCT)
The Skyscan 1076 X-ray computed microtomograph (SkyscanKontich, Belgium) was used in the cone beam acquisition mode. The system is composed of a sealed microfocus X-ray tube, air cooled with a spot size less than 8 lm, and a CCD camera. Images were obtained at 80 kV and 120 lA with a 1 mm aluminum filter, the pixel size was 18.96 lm and a 0.45°rotation angle at each step. Specimens were placed in a plastic test tube filled with the fixative. Tubes were fixed with plasticine on the brass stub of the microCT. Two-dimensional (2D) section images were stored in the bmp format with indexed gray levels ranging from 0 (black) to 255 (white) that served to reconstruct 3D models with programs provided by the manufacturer (softwares used: ANT release # 2.4.3 and Ct-An 1.8). The ANT program allows reconstruction of 3D models from the stack of 2D sections after interactive segmentation. The histomorphometric parameters were recorded in compliance with the recommendation of the American Society for Bone and Mineral Research (ASBMR) Histomorphometry Nomenclature Committee [22] . The Ct-An software provided the following parameters after determination of the volume of interest (VOI) comprising the whole grafted area. VOI was obtained by tracing polygons on 2D images separated by approximately 50 lm; an algorithm interpolated the polygons with the intermediate sections.
The bone volume (BV/TV, in %) is the ratio of the volume of bone present (BV) to the total VOI (i.e., TV). The Material volume (MatV/TV, in %) is the ratio of the volume of the remaining amount of b-TCP presen to the VOI. MatV/TVcould be determined because the radio-opacity of b-TCP was higher than bone and allowed a selective thresholding.
Trabecular thickness (in lm) was measured separately in the newly formed trabeculae in the grafted bone (Tb g .Th) and in the mature trabeculae of the epiphysis, at distance from the graft (Tb e .Th).
Histology after undecalcified processing
Bones were embedded undecalcified in poly(methyl methacrylate). The infiltration of bone samples and the embedding process were performed in a cold environment as previously described [23] . Sections 7 lm in thickness were cut dry using a microtome with carbide tungsten knives (Microtome Leica Polycut S). Staining was performed with a modification of the toluidine blue borax method. Unstained sections were used to quantify the amount of fluorescent microbeads by fluorescence microscopy (Olympus BX51 Microscope, excitation cube U-MWIG2) both in the zone grafted and in the marrow spaces of the epiphysis. A microscopic eyepiece comprising a rectangular reticle of known surface was used to count the number of macrophagic cells containing clusters of microbeads on several contiguous fields. The number of microbeads by surface unit was calculated separately in the grafted area (Mb.N/T.Ar g ) and at distance in the ungrafted cancellous spaces of the epiphysis (Mb.N/T.Ar e ).
Statistical analysis
Statistical analysis was performed using Systat Ò statistical software release 11.0 (Systat Software, San Jose, CA). Differences among groups were searched with the Kruskal-Wallis One-Way Analysis of Variance and differences between groups by MannWhitney's U test when the ANOVA revealed a significant difference. Differences were considered as significant when p < 0.05. Results were expressed as mean standard deviation.
Results

Granules morphology
Using scanning electron microscopy, the material appeared composed of large round cavities. Internal voids (created by the disappearance of the polymer foam) were observed ( Fig. 2A) . The surface of the material appeared composed of a regular paving composed of geometric tiles with a rounded top (Fig. 2B ).
X-ray analysis
X-ray images show that the biomaterial was hardly evidenced due to its higher radio-opacity (Fig. 3) . However, the osteoconduction could not be evidenced because the epiphyseal trabeculae overimposed onto the material granules and the newly formed bone. Fig. 3 . X-ray image of a control rabbit femur (A) and a femur grafted with b-TCP granules and examined at 8 days.
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MicroCT
At 8 days, the porous granules of b-TCP were easily observable on 2D images. They appeared more radio-opaque than bone itself, rabbits having received or not ketoprofen. The granules retained their polygonal shape with sharp angles and the internal porosity due to the manufacture process was easily recognizable, indicating that resorption of the biomaterial had remained limited at this stage. On the other hand, osteogenesis has yet begun and appeared in the form of thin trabeculae advancing in the direction of the grafted zone in a centripetal way starting from the vicinal trabeculae of the epiphysis (Figs. 4A,B and 5A ). These trabeculae were less radio-opaque than the mature bone trabeculae on the 2D sections and their microarchitecture evoked metaplastic bone (woven bone).
At 28 days, many bÀTCP granules presented a coarsely round shape and a reduction of their size was obvious. A larger number of thin metaplastic trabeculae were observed around the grafted area and extending between the biomaterial granules (Figs. 4C-E and 5B). bÀTCP appeared partially reabsorbed and the centripetal osteogenesis progressed inside the grafted area.
No gross morphological differences could be observed between the groups of animals treated or not with ketoprofen (neither at 8 nor at 28 days).
The volume of newly formed bone in the zone of graft (BV/TV) did not significantly differ for between the groups D8K À and D8K + at 8 days, however; BV/TV increased significantly at D28 (p < 0.001) (Fig. 6A) . MatV/TV did not differ among groups at D8 or D28 but was signigicantly reduced in all groups at D28 (p < 0.001). No significant difference between the 3 groups was observed at 28 days. The thickness of the trabeculae in the epiphysis (Tb e .Th) was similar in all groups and did not vary between D8 and D28. Tb g .Th was significantly lower in the metaplastic trabeculae compared to Tb e .Th (p < 0.0001). A significant difference was observed for Tb g .Th between the groups at 8 days and at 28 days (p < 0.0001) with a moderate increased thickness of approximately 13 lm (Fig. 6B) . Ketoprofen had no influence on the trabecular thickness of the metaplastic bone trabeculae at any time.
Histology
Histological analysis revealed the presence of a non-inflammatory loose connective tissue (made of mesenchymal cells) between the b-TCP granules and the newly formed bone trabeculae. The mesenchymal reaction was always highly vascular with numerous sinusoid capillaries. The center of the connective tissue areas always contained numerous macrophages filled with minute particles of b-TCP (Fig. 7) . Some giant cells and osteoclast-like cells were also found at the surface of the biomaterial. Histological findings confirmed microCT data with metaplastic bone extending from the surrounding areas to the grafted b-TCP granules. At D28, the amount of metaplastic bone was important and trabeculae were found directly apposed onto the surface of the biomaterial. A number of pseudo-epithelial alignments of osteoblasts were observed at surface of newly formed bone on the biomaterial granules. The number of microbeads was evaluated in fluorescence microscopy in the zone grafted and compared with the remainder of marrow spaces of the epiphysis. A very limited number of microbeads was observed in marrow spaces of the grafted zone in which the mesenchymal area had developed between the grains (Fig. 6C) . On the contrary, Mb.N/T.Ar e was significantly higher, meaning that a large number of macrophagic cells appeared loaded with microbeads in the remainder of marrow spaces of the epiphysis (Fig. 8A,B ).
There were no difference for Mb.N/T.Ar g according to the treatment by ketoprofen between the groups D8K À and D8K + at 8 days, nor between the 3 groups at 28 days. No significant difference between the groups was observed for Mb.N/T.Ar e whatever the duration of the study or the treatment.
Discussion
The use of porous calcium phosphate granules is recognized as filler or packing biomaterials in an osseous environment. Therefore, b-TCP is used as a bone substitute in oral and maxillofacial surgery for alveolar socket filling after tooth extraction [24] or maxillary sinus floor elevation [25, 26] . Although autologous bone is considered as the best material for such techniques, the increased morbidity (due to the harvesting of bone in another surgical location in the same patient) has led to other techniques being developed. In addition, the use of synthetic biomaterials such as b-TCP is reported to be associated with a lower (or the same) risk of failure or complications [5] . In orthopedic surgery, b-TCP granules are seldom used because of the friability of the material in weightbearing areas although interesting results have been presented [27, 28] . In the present study, commercially available b-TCP granules were use as a bone filler in a critical size defect performed in the femoral condyle of the rabbit. Ketoprofen was used as an anti-inflammatory drug to evaluate its effects on the bone in growth induced by b-TCP in this model.
NSAID and cyclo-oxygenase-2 (COX-2) inhibitors are commonly prescribed after orthopedic or maxillofacial surgery, and their antiinflammatory effects are due to their impairment of COX-1 and/or COX-2. These compounds have not the deleterious effects on bone cells and remodeling of glucocorticoids (see review by Bouvard [29] ). However, long term use of NSAID has been repeatedly reported to interfere with bone remodeling and to delay bone healing [30] [31] [32] . Similar findings have been found in a number of animal studied [33, 34] . However, more recent findings have shown that, when given for shorter periods of times (e.g. 2-6 weeks in New Zealand rabbits), the deleterious effects are less pronounced [35, 36] , allowing the patients to benefit from the analgesic and anti-inflammatory properties of these compounds. Because the clinical scenario after orthopedic (or oral and maxillofacial surgery) is presently more to prescribe a low dose of NSAID for a short duration, this study was designed with two regimens (8 days and 28 days) during the healing phase of a bone graft. None of the two regimens had influence on the amount of bone deposited or on the microarchitectural quality of the trabeculae formed by osteoconduction induced by b-TCP. Ketoprofen is an NSAID with an antiCOX-1 and antiCOX-2 activity; however, little is known concerning the level of the two isoforms of COX at the grafted site of a bone biomaterial or in a fracture callus [37] . In this study, the onset of metaplastic bone formation occurred rapidly since the first trabeculae could be identified as early as 8 days post-grafting. Similar findings have been reported in the rat grafted with b-TCP in which thin trabeculae were observed as early as 7 days post-surgery [38] . Ketoprofen did not delay the centripetal bone formation starting from the vicinal trabeculae at the periphery of the implantation area. It should also be reminded that selective COX-2 inhibitors have been found to have serious cardio-vascular side effects and some (rofecoxib, Vioxx Ò ) have now been withdrawn over safety concerns [39, 40] .
Microbeads are a useful tool to study the angiogenesis in tumors and could be used to deliver locally high amounts of angio- genic inhibitors [41] . pHEMA is a well recognized polymer in biomedicine [42] and microbeads can be readily prepared. In this study, microbeads containing Nile red were prepared as a fluorescent tracer for endothelial cells and macrophages. Microbeads can be rapidly trapped by endothelial cells (particularly in the case of rapid angiogenesis) and phagocytosed by macrophages in the stroma of the tissues [19] . This as been recognized as the enhanced permeability retention effect [41, 43, 44] . Methacrylate-based polymers can be easily prepared in the form of microbeads or nanobeads usable as carriers [45] . In addition, we previously showed that macrophages can phagocytose and internalize the pHEMA hydrogel [46] . In this study, the rabbits were euthanized 4 h after injection of the microbeads, a time sufficient to allow their internalization by macrophages at the periphery of the sinusoid capillaries of the bone marrow. The number of fluorescently labeled macrophages was much lower in the grafted zone than in the ungrafted cancellous areas of the epiphysis. Although the number of macrophages has been recognized to be increased in the mesenchymal reaction around b-TCP granules [47] [48] [49] , this finding may appear intriguing. However, macrophages in the grafted area were filled with b-TCP particles and they are probably less susceptible to internalize a new type of material. NSAIDs can reduce the macrophagic function in inflammatory diseases [50] . Here again, the amount of labeled macrophages did not differ in the ketoprofen-treated groups from the control ones, either in the short or the longer periods of analysis.
b-TCP granules, implanted in a critical size defect in the rabbit, induced the rapid and extensive proliferation of bone trabeculae, starting from the margins of the implantation area. Ketoprofen, given for 8 or 28 days, had no effect on osteogenesis or on the uptake of fluorescent microbeads by activated macrophages in the grafted area. Although NSAIDs (given for a long period of time) are known to delay fracture healing, their effect in short time treatment on a biomaterial graft healing appear insignificant.
